Glenda S. Overbeck
Directeur/Membre du Conseil chez Oncovance Technologies, Inc.
Profil
Glenda S.
Overbeck is currently a Director at Oncovance Technologies, Inc. and Prokaryon Technologies, Inc. She previously worked as a Vice President at BCM Technologies, Inc. from 2000 to 2009.
She also held positions as an Associate at Houston Partners and as a Principal at Progression Therapeutics, Inc. Ms. Overbeck obtained her undergraduate degree and an MBA from Pittsburg State University.
Postes actifs de Glenda S. Overbeck
| Sociétés | Poste | Début |
|---|---|---|
Oncovance Technologies, Inc.
 Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Oncovance Technologies, Inc. provides information management and analytical services and solutions to the healthcare industry. It provides database and information management to pharmaceutical and medical device manufacturers to promote and differentiate therapeutics, IT tools that improve and personalize treatment decisions & support physician users, and platforms to drive diagnostics development and sales. The company was founded by Kevin M. Slawin, Peter T. Scardino, and Michael W. Kattan and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 18/08/2009 |
Prokaryon Technologies, Inc.
 Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Prokaryon Technologies, Inc., is a animal health company that develops solutions for the prevention and control of economically devastating diseases in food animals. The focus of the company is the discovery, development, and commercialization of innovative veterinary products. Prokaryon's lead product is a genomics-derived vaccine to prevent shipping fever in cattle | Directeur/Membre du Conseil | 17/08/2009 |
Anciens postes connus de Glenda S. Overbeck
| Sociétés | Poste | Fin |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Private Equity Investor | 30/06/2009 |
Houston Partners
 Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Corporate Officer/Principal | 31/12/1999 |
Progression Therapeutics, Inc.
 Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 19/08/2009 |
Formation de Glenda S. Overbeck
| Pittsburg State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Finance |
Oncovance Technologies, Inc.
Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Oncovance Technologies, Inc. provides information management and analytical services and solutions to the healthcare industry. It provides database and information management to pharmaceutical and medical device manufacturers to promote and differentiate therapeutics, IT tools that improve and personalize treatment decisions & support physician users, and platforms to drive diagnostics development and sales. The company was founded by Kevin M. Slawin, Peter T. Scardino, and Michael W. Kattan and is headquartered in Houston, TX. | Technology Services |
Prokaryon Technologies, Inc.
Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Prokaryon Technologies, Inc., is a animal health company that develops solutions for the prevention and control of economically devastating diseases in food animals. The focus of the company is the discovery, development, and commercialization of innovative veterinary products. Prokaryon's lead product is a genomics-derived vaccine to prevent shipping fever in cattle | Health Technology |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Health Technology |
